Table of Contents Author Guidelines Submit a Manuscript
International Journal of Chronic Diseases
Volume 2015, Article ID 290128, 6 pages
http://dx.doi.org/10.1155/2015/290128
Research Article

Relationship between Helicobacter pylori Infections in Diabetic Patients and Inflammations, Metabolic Syndrome, and Complications

1Division of Gastroenterology, Internal Medicine Department, Bezmialem Vakif University, Turkey
2Internal Medicine Department, Şişli Etfal Training and Research Hospital, Turkey
3Sisli Etfal Hamidiye Education and Research Hospital, Clinics of Internal Medicine, Turkey

Received 18 August 2014; Revised 10 December 2014; Accepted 21 December 2014

Academic Editor: Kathleen Gillespie

Copyright © 2015 Yusuf Kayar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. E. Pounder and D. Ng, “The prevalence of Helicobacter pylori infection in different countries,” Alimentary Pharmacology & Therapeutics, vol. 9, supplement 2, pp. 33–39, 1995. View at Google Scholar · View at Scopus
  2. B. R. Devrajani, S. Z. A. Shah, A. A. Soomro, and T. Devrajani, “Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: a hospital based case-control study,” International Journal of Diabetes in Developing Countries, vol. 30, no. 1, pp. 22–26, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Vafaeimanesh, M. Parham, M. Seyyedmajidi, and M. Bagherzadeh, “Helicobacter pylori infection and insulin resistance in diabetic and nondiabetic population,” Scientific World Journal, vol. 2014, Article ID 391250, 5 pages, 2014. View at Publisher · View at Google Scholar
  4. M. Talebi-Taher, M. Mashayekhi, M. H. Hashemi, and V. Bahrani, “Helicobacter pylori in diabetic and non-diabetic patients with dyspepsia,” Acta Medica Iranica, vol. 50, no. 5, pp. 315–318, 2012. View at Google Scholar · View at Scopus
  5. S. A. Hamed, N. F. Amine, G. M. Galal et al., “Vascular risks and complications in diabetes mellitus: the role of Helicobacter pylori infection,” Journal of Stroke and Cerebrovascular Diseases, vol. 17, no. 2, pp. 86–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. G. E. Chung, N. J. Heo, M. J. Park, S. J. Chung, H. Y. Kang, and S. J. Kang, “Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria,” World Journal of Gastroenterology, vol. 19, no. 1, pp. 97–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Sargin, O. Uygur-Bayramiçli, H. Sargýn, E. Orbay, D. Yavuzer, and A. Yayla, “Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori,” World Journal of Gastroenterology, vol. 9, no. 5, pp. 1126–1128, 2003. View at Google Scholar · View at Scopus
  8. N. J. Talley, L. Young, P. Bytzer et al., “Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life,” The American Journal of Gastroenterology, vol. 96, no. 1, pp. 71–76, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Demir, H. S. Gokturk, N. A. Ozturk, M. Kulaksizoglu, E. Serin, and U. Yilmaz, “Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications,” Digestive Diseases and Sciences, vol. 53, no. 10, pp. 2646–2649, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C.-H. Tseng, “Diabetes, insulin use and Helicobacter pylori eradication: a retrospective cohort study,” BMC Gastroenterology, vol. 12, article 46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-H. Ni, J.-T. Lin, S.-F. Huang, J.-C. Yang, and M.-H. Chang, “Accurate diagnosis of Helicobacter pylori infection by stool antigen test and 6 other currently available tests in children,” Journal of Pediatrics, vol. 136, no. 6, pp. 823–827, 2000. View at Google Scholar · View at Scopus
  12. S. Gentile, S. Turco, B. Oliviero, and R. Torella, “The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 42, no. 1, pp. 41–48, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Marrollo, G. Latella, D. Melideo et al., “Increased prevalence of Helicobacter pylori in patients with diabetes mellitus,” Digestive and Liver Disease, vol. 33, no. 1, pp. 21–29, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Anastasios, C. Goritsas, C. Papamihail, R. Trigidou, P. Garzonis, and A. Ferti, “Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings,” European Journal of Internal Medicine, vol. 13, no. 6, pp. 376–379, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Franceschi, A. R. Sepulveda, A. Gasbarrini et al., “Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis,” Circulation, vol. 106, no. 4, pp. 430–434, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. C. M. Bliss Jr., D. T. Golenbock, S. Keates, J. K. Linevsky, and C. P. Kelly, “Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes,” Infection and Immunity, vol. 66, no. 11, pp. 5357–5363, 1998. View at Google Scholar · View at Scopus
  17. J. E. Crabtree, T. M. Shallcross, R. V. Heatley, and J. I. Wyatt, “Mucosal tumour necrosis factor α and interleukin-6 in patients with Helicobacter pyloris associated gastritis,” Gut, vol. 32, no. 12, pp. 1473–1477, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. A. E. Kratnov and O. N. Pavlov, “Helicobacter pylori infection and state of antioxidant protection in patients with the unstable course of ischemic disease,” Eksperimental'naia i Klinicheskaia Gastroenterologiia, vol. 145, no. 5, pp. 4–9, 2004. View at Google Scholar · View at Scopus
  19. L. A. Harker, R. Ross, S. J. Slichter et al., “Homocystine induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis,” The Journal of Clinical Investigation, vol. 58, no. 3, pp. 731–741, 1976. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Majka, T. Róg, P. C. Konturek et al., “Influence of chronic Helicobacter pylori infection on ischemic cerebral stroke risk factors,” Medical Science Monitor, vol. 8, no. 10, pp. 675–684, 2002. View at Google Scholar · View at Scopus
  21. T. Gunji, N. Matsuhashi, H. Sato et al., “Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population,” American Journal of Gastroenterology, vol. 103, no. 12, pp. 3005–3010, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Gunji, N. Matsuhashi, H. Sato et al., “Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population,” Helicobacter, vol. 14, no. 5, pp. 144–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Zojaji, E. Ataei, S. J. Sherafat, M. Ghobakhlou, and S. R. Fatemi, “The effect of the treatment of Helicobacter pylori infection on the glycemic control in type 2 diabetes mellitus,” Gastroenterology and Hepatology from Bed to Bench, vol. 6, no. 1, pp. 36–40, 2013. View at Google Scholar · View at Scopus
  24. V. Zweet and F. Megraud, “Diagnosis,” Current Opinion in Gastroenterology, vol. 14, supplement 1, pp. S27–S33, 1998. View at Google Scholar